This afternoon at 4:12pm PST #AACR26, Dr. Pat LoRusso presents updates on dose escalation results from a Phase 1 study of #ZW191 during a...

AACR 2026 现场信号· @ · X·2026-04-22 05:00· 2026-04-22Score60

Body · original

This afternoon at 4:12pm PST #AACR26, Dr. Pat LoRusso presents updates on dose escalation results from a Phase 1 study of #ZW191 during a #clinicaltrials mini-symposium. https://t.co/sHcYw4rrQW
@SmilowCancer @AACR https://t.co/0u615wXCyr

Heat 4 · 4 likes · 0 replies · 0 reposts

Conference abstracts

CT306NCT06555744matched by 代号 ZW191

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results

Patricia LoRusso, David Sommerhalder, Kosei Hasegawa, Kenichi Harano, David S. Tan, Noboru Yamamoto, David M. O’Malley, Kathleen N. Moore, Sarah E. Church, Lin Lu, Sabeen Mekan, Pranshul Chauha, Jung-Yun Lee

Read the abstract →

Source: AACR 2026 现场信号 · x.com